Logo Image
News
All NewsDosing & Delivery InnovationsPress ReleasesProduct Approvals and Launches
Watch
Expert ConversationsNews & AnalysisShows & Podcasts
Journals
All JournalsThe American Journal of Managed CarePopulation Health, Equity & OutcomesEvidence-Based OncologyAbout Supplements and Featured PublicationsSupplements and Featured Publications IssuesSubmit a Manuscript
Conferences
Conference CoverageConference ListingPost Conference Perspectives
More
Events
AJMC EventsEvents CalendarInstitute for Value-Based MedicinePatient-Centered Oncology CarePopulation Health RoundtablesWebinars
Resources
Interactive ToolsFormulary CentralClinical SpotlightMicrositesSponsored Content
CE
About AJMC
AJMC StaffAnniversarySeema Sonnad AwardStrategic Alliance Partners

Subscribe

  • News
  • Watch
  • Journals
  • Conferences
  • Events
  • Resources
  • CE
  • About AJMC
  • Subscribe
  • Biosimilars
  • Cardiorenalmetabolic
    • Cardiomyopathy
    • Cardiovascular
    • Chronic Kidney Disease
    • Diabetes
    • Heart Failure
    • Type 1 Diabetes
  • Dermatology
    • Alopecia
    • Atopic Dermatitis
    • Chronic Hand Eczema
    • Psoriasis
  • Gastroenterology
  • Hematology
    • ALL/AML
    • CLL/SLL
    • GVHD
    • Hemophilia
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myelodysplastic Syndromes
    • Myeloproliferative Neoplasms
    • Non-Hodgkin Lymphoma
    • Rare Blood
  • Hepatology
    • Hepatitis
    • Liver
    • MASH
  • Immunology
    • Allergy
    • Autoimmune
    • Inflammation
    • Lupus
    • Myasthenia Gravis
    • Rheumatoid Arthritis
  • Infectious Disease
    • COVID-19
    • HIV
    • RSV
    • Vaccines
  • Mental Health
    • Major Depressive Disorder
    • Sleep
  • Neurology
    • Duchenne Muscular Dystrophy
    • Epilepsy
    • Multiple Sclerosis
    • Parkinson Disease
  • Obesity
  • Oncology
    • Breast Cancer
    • Cholangiocarcinoma
    • Colorectal Cancer
    • Immuno-Oncology
    • Liver Cancer
    • Non–Small Cell Lung Cancer
    • Ovarian Cancer
    • Prostate Cancer
    • Skin Cancer
    • Small Cell Lung Cancer
    • Soft Tissue Sarcoma
  • Ophthalmology
  • Pulmonology
    • COPD
    • Pulmonary Arterial Hypertension
  • Rare Disease
    • Spinal Muscular Atrophy
  • Respiratory
    • Asthma
    • Bronchiectasis
    • Pulmonary Fibrosis
  • Rheumatology
    • Sjögren Disease
  • Urology
    • Overactive Bladder
  • Women's Health
    • Endometriosis
    • Reproductive Health
  • Biosimilars
  • Bispecifics Network
  • Center on Health Equity & Access
  • Digital Health
  • Dosing & Delivery Innovations
  • Formulary
  • Gene Therapy
  • Guidelines
  • Health Care Administration
    • Employers
    • Medicare
    • Reimbursement
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Population Health
  • Product Approvals and Launches
  • Technology
  • Value-Based Care
Spotlight -
Free In-Person Regional Events Focused on Oncology and Population Health
Advertisement

Brooke Peters, PharmD, BCOP

Advertisement

Articles by Brooke Peters, PharmD, BCOP

Closing the Gap: How AON Turns AI and the Patient Voice Into Practice

ByLaura Joszt, MA,Brooke Peters, PharmD, BCOP,Melody Chang, RPh, MBA, BCOP,Stephen G. Divers, MD,Puneeth Indurlal, MD
October 2nd 2026

AI, patient voice in pathways, and caregiver support are shaping community oncology, AON leaders said at Patient-Centered Oncology Care.

Brooke Peters, PharmD, BCOP | Image Credit: © American Oncology Network

Community Pharmacists Are Redefining Bispecific Antibody Care Beyond Academic Centers: Brooke Peters, PharmD, BCOP

ByMaggie L. Shaw,Brooke Peters, PharmD, BCOP
May 12th 2026

Community pharmacists must build scalable workflows as bispecific antibodies move into earlier lines and outpatient settings, notes Brooke Peters, PharmD, BCOP, of AON.

Advertisement

Latest Updated Articles

  • Brooke Peters, PharmD, BCOP | Image Credit: © American Oncology Network
    Community Pharmacists Are Redefining Bispecific Antibody Care Beyond Academic Centers: Brooke Peters, PharmD, BCOP

    May 12th 2026

  • Closing the Gap: How AON Turns AI and the Patient Voice Into Practice
    Closing the Gap: How AON Turns AI and the Patient Voice Into Practice

    October 2nd 2026



Advertisement
Advertisement

Trending on AJMC

1

FDA Approves Once-Monthly Subcutaneous Olanzapine for Schizophrenia

2

FDA Approves IV, Subcutaneous Atezolizumab for dMMR Colon Cancer

3

Bumetanide Nasal Spray Targets Heart Failure Edema Before IV

4

Timing COVID-19 Protection With VYD2311: Michael Mina, MD, PhD

5

PhRMA Sues to Block CMS Most Favored Nation Model for Part B

Brand Logo
  • About
  • Contact
  • Editorial Boards
  • Advertise
  • Do Not Sell My Information
  • Terms & Conditions
  • Privacy Policy

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2026 MJH Life Sciences®

All rights reserved.

Secondary Brand Logo
Alt TextAlt Text